Gain Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Gain Therapeutics (GANX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Gain Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Gain Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Gain Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $138k | 77k | 1.80 |
| 2024-12-31 | $191k | 89k | 2.16 |
| 2024-09-30 | $8.5k | 4.8k | 1.78 |
| 2024-06-30 | $4.2k | 3.3k | 1.28 |
| 2024-03-31 | $11k | 2.8k | 3.77 |
| 2023-12-31 | $9.1k | 2.8k | 3.27 |
| 2023-09-30 | $4.3k | 1.3k | 3.28 |
| 2023-06-30 | $3.6k | 800 | 4.48 |
| 2022-12-31 | $2.5k | 800 | 3.13 |
| 2022-06-30 | $3.0k | 800 | 3.75 |
| 2022-03-31 | $0 | 803 | 0.00 |
| 2021-06-30 | $8.0k | 800 | 10.00 |